AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33827091 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IL-8 concentrations
Number of subjects: 95
Study 32069121 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.12
Number of subjects: 12
Study 32069121 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.145
Number of subjects: 12
Study 32069121 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.17
Number of subjects: 12
Study 32069121 — intervention group
Group type: EXPERIMENTAL
Intervention: FIO2 0.21
Number of subjects: 12
Study 35502412 — intervention group
Group type: EXPERIMENTAL
Intervention: Shugan Jianpi recipe combined with cross moxibustion
Number of subjects: 60
Study 35502412 — intervention group
Group type: COMPARATOR
Intervention: Chang Shugan Jianpi recipe
Number of subjects: 60
Study 35178737 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotora de Salud program
Number of subjects: 0
Study 35178737 — intervention group
Group type: COMPARATOR
Intervention: Standard education group
Number of subjects: 0
Study 34628908 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led early rehabilitation program
Number of subjects: 80
Study 34628908 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 80
Study 32889867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus for ≥3 months after LT for HCC
Number of subjects: 508
Study 32889867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus for ≥3 months after LT for HCC in patients with AFP ≥10 ng/mL
Number of subjects: 508
Study 36119938 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective motivation intervention nursing
Number of subjects: 60
Study 33994886 — intervention group
Group type: EXPERIMENTAL
Intervention: CN injection group
Number of subjects: 108
Study 33994886 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study 33994886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 32924553 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture Therapy (AT)
Number of subjects: 855
Study 32924553 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 855
Study 35581169 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent-focused Cash Plus intervention (12-session course + 9 months of mentoring, productive grants, and strengthened health services)
Number of subjects: 2458
Study 35581169 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2458
Study 34075857 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-method recovery intervention (MMR) consisting of active recovery, stretching, cold-water immersion, and massage
Number of subjects: 9
Study 34075857 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (PAS)
Number of subjects: 9
Study 33164729 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraception Choices website
Number of subjects: 927
Study 33164729 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 927
Study 35639946 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus sheath infiltration with bupivacaine
Number of subjects: 150
Study 35639946 — intervention group
Group type: COMPARATOR
Intervention: No infiltration
Number of subjects: 150
Study 35639946 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous infiltration
Number of subjects: 150
Study 35639946 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (no infiltration, subcutaneous infiltration, rectus sheath infiltration)
Number of subjects: 150
Study 34184312 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum block with liposomal bupivacaine
Number of subjects: 92
Study 34184312 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 92
Study 32154936 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin (90 mg twice daily plus 100 mg once daily)
Number of subjects: 231
Study 32154936 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor alone (90 mg twice daily)
Number of subjects: 231
Study 32154936 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin alone (100 mg once daily)
Number of subjects: 231
Study 32154936 — intervention group
Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 231
Study 34365456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP) wound dressing
Number of subjects: 10
Study 34365456 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 10
Study 32475312 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction with slow sodium tablets for 6 weeks
Number of subjects: 145
Study 32475312 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets for 6 weeks
Number of subjects: 145
Study 32475312 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction in females
Number of subjects: 145
Study 32475312 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium reduction in males
Number of subjects: 145
Study 35084912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis users (n = 25)
Number of subjects: 47
Study 35084912 — intervention group
Group type: COMPARATOR
Intervention: Non-cannabis users (n = 22)
Number of subjects: 47
Study 35084912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use days and cannabis use disorder symptoms
Number of subjects: 47
Study 34138875 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (PM+), a psychological treatment of 5 weekly sessions
Number of subjects: 611
Study 34138875 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (PM+)
Number of subjects: 611
Study 34138875 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 611
Study 33357420 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pertuzumab (840 mg loading dose, followed by 420 mg maintenance doses) plus intravenous trastuzumab (8 mg/kg loading dose, followed by 6 mg/kg maintenance doses)
Number of subjects: 500
Study 33357420 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (1200 mg pertuzumab plus 600 mg trastuzumab loading dose, followed by 600 mg pertuzumab plus 600 mg trastuzumab maintenance doses)
Number of subjects: 500
Study 32688414 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-joint to single-joint order (MJ-SJ)
Number of subjects: 45
Study 32688414 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-joint to multi-joint order (SJ-MJ)
Number of subjects: 45
Study 32688414 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating between upper and lower body order (ALT)
Number of subjects: 45
Study 35268033 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 50
Study 35268033 — intervention group
Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 50
Study 33592837 — intervention group
Group type: EXPERIMENTAL
Intervention: rESWT on acupuncture points during the follicular phase (Group A, n=15)
Number of subjects: 44
Study 33592837 — intervention group
Group type: EXPERIMENTAL
Intervention: rESWT on acupuncture points during the luteal phase (Group B, n=14)
Number of subjects: 44
Study 33592837 — intervention group
Group type: COMPARATOR
Intervention: Heat patch on acupuncture points during the follicular phase (Group C, n=15)
Number of subjects: 44
Study 33092583 — intervention group
Group type: EXPERIMENTAL
Intervention: PBL-CBL teaching method
Number of subjects: 586
Study 33092583 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture-based classroom group
Number of subjects: 586
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: hsCRP (high-sensitivity C-reactive protein)
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 (interleukin-6)
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C (low-density lipoprotein cholesterol)
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: non-HDL-C (non-high-density lipoprotein cholesterol)
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: hsCRP
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C
Number of subjects: 9151
Study 35943897 — intervention group
Group type: EXPERIMENTAL
Intervention: non-HDL-C
Number of subjects: 9151
Study 34323282 — intervention group
Group type: COMPARATOR
Intervention: Direct ET
Number of subjects: 352
Study 34323282 — intervention group
Group type: EXPERIMENTAL
Intervention: Afterload ET
Number of subjects: 352
Study 32724270 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Automated Perimetry (SAP)
Number of subjects: 180
Study 32724270 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency Doubling Technology (FDT)
Number of subjects: 180
Study 32724270 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 180
Study 32724270 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 180
Study 35187687 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre-near multifocal soft contact lenses with a 2.00 D add for 2 years
Number of subjects: 22
Study 35187687 — intervention group
Group type: COMPARATOR
Intervention: Single vision spectacles
Number of subjects: 22
Study 33819178 — intervention group
Group type: EXPERIMENTAL
Intervention: PXVX0200
Number of subjects: 73
Study 34475522 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg of saracatinib
Number of subjects: 43
Study 34475522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 34475898 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-operative treatment (NOT) with intravenous Meropenem and Metronidazole for 48 hours followed by oral antibiotics for 7 days (Group A)
Number of subjects: 180
Study 34475898 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy (Group B)
Number of subjects: 180
Study 34475898 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-operative treatment (NOT) with failure
Number of subjects: 180
Study 34413344 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP-NF
Number of subjects: 67
Study 34413344 — intervention group
Group type: EXPERIMENTAL
Intervention: fNIRS-NF
Number of subjects: 67
Study 34413344 — intervention group
Group type: COMPARATOR
Intervention: EMG-BF
Number of subjects: 67
Study 32950728 — intervention group
Group type: EXPERIMENTAL
Intervention: 38 % SDF and potassium iodide (KI)
Number of subjects: 60
Study 32950728 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioner polyacrylic acid (PAA)
Number of subjects: 60
Study 32950728 — intervention group
Group type: EXPERIMENTAL
Intervention: 38 % SDF
Number of subjects: 60
Study 32950728 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 60
Study 32950728 — intervention group
Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 60
Study 35081671 — intervention group
Group type: EXPERIMENTAL
Intervention: Systems Training for Emotional Predictability and Problem Solving (STEPPS) program
Number of subjects: 164
Study 35081671 — intervention group
Group type: EXPERIMENTAL
Intervention: High severity (HS) class (26%)
Number of subjects: 164
Study 35081671 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective instability/substance abuse (AISA) class (16%)
Number of subjects: 164
Study 35081671 — intervention group
Group type: EXPERIMENTAL
Intervention: Empty/dissociation/identity disturbance (EDID) class (27%)
Number of subjects: 164
Study 35081671 — intervention group
Group type: EXPERIMENTAL
Intervention: Low severity (LS) class (30%)
Number of subjects: 164
Study 33969450 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-irradiated implants
Number of subjects: 34
Study 33969450 — intervention group
Group type: COMPARATOR
Intervention: Conventional commercial implants
Number of subjects: 34
Study 32408374 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies in homeopathy
Number of subjects: 0
Study 32408374 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35801618 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) treatment by inexperienced physicians
Number of subjects: 720
Study 35801618 — intervention group
Group type: COMPARATOR
Intervention: High-intensity focused ultrasound (HIFU) treatment by experienced physicians
Number of subjects: 720
Study 35801618 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning group (inexperienced physicians)
Number of subjects: 720
Study 35801618 — intervention group
Group type: COMPARATOR
Intervention: Control group (experienced physicians)
Number of subjects: 720
Study 32345329 — intervention group
Group type: EXPERIMENTAL
Intervention: PE + Peer Support (in vivo peer support during homework for 3-4 weeks)
Number of subjects: 150
Study 32345329 — intervention group
Group type: COMPARATOR
Intervention: PE + Peer Support (weekly peer calls for 3-4 weeks)
Number of subjects: 150
Study 36484087 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerec™ software (CR)
Number of subjects: 95
Study 36484087 — intervention group
Group type: EXPERIMENTAL
Intervention: PrepCheck™ software (PC)
Number of subjects: 95
Study 36484087 — intervention group
Group type: COMPARATOR
Intervention: Silicon keys (C)
Number of subjects: 95
Study 32540179 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT system
Number of subjects: 102
Study 32540179 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 102
Study 35850010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Troponins (hs-cTnI, hs-cTnT) and NT-proBNP
Number of subjects: 4102
Study 35850010 — intervention group
Group type: COMPARATOR
Intervention: Cardiac markers (hs-cTnI, hs-cTnT, NT-proBNP)
Number of subjects: 4102
Study 34879499 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine
Number of subjects: 140
Study 34879499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 33573766 — intervention group
Group type: EXPERIMENTAL
Intervention: Forecasting Your Future: Nutrition Matters training
Number of subjects: 35
Study 33573766 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual curriculum)
Number of subjects: 35
Study 32945898 — intervention group
Group type: EXPERIMENTAL
Intervention: GH
Number of subjects: 9
Study 32945898 — intervention group
Group type: EXPERIMENTAL
Intervention: GH+acipimox
Number of subjects: 9
Study 32945898 — intervention group
Group type: EXPERIMENTAL
Intervention: acipimox
Number of subjects: 9
Study 32945898 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 9
Study 34125980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoke extract (CSE) treatment in 16HBE cells
Number of subjects: 0
Study 34125980 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAT1 silencing
Number of subjects: 0
Study 34125980 — intervention group
Group type: EXPERIMENTAL
Intervention: miR‐181a‐5p inhibition
Number of subjects: 0
Study 34125980 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAT1 expression
Number of subjects: 0
Study 34125980 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAT1
Number of subjects: 0
Study 35442091 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV) applied at 6-month intervals
Number of subjects: 534
Study 35442091 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - multicomponent national child oral health improvement intervention (Childsmile program) excluding nursery FV
Number of subjects: 534
Study 34229624 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative electronic trial recruitment and outcomes software
Number of subjects: 16
Study 34229624 — intervention group
Group type: COMPARATOR
Intervention: External IT support
Number of subjects: 16
Study 34229624 — intervention group
Group type: COMPARATOR
Intervention: Approval processes for new software
Number of subjects: 16
Study 32611327 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant radiotherapy (RT) in addition to standard postoperative treatment of HBV/HCV and nutritional therapy
Number of subjects: 59
Study 32611327 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative treatment of HBV/HCV and nutritional therapy (Control)
Number of subjects: 59
Study 32611327 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant radiotherapy (RT)
Number of subjects: 59
Study 34320659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 30
Study 34219633 — intervention group
Group type: EXPERIMENTAL
Intervention: Arabin pessary plus standard care
Number of subjects: 503
Study 34219633 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 503
Study 32709514 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrust Joint Manipulation (TJM)
Number of subjects: 67
Study 32709514 — intervention group
Group type: COMPARATOR
Intervention: Sham Manipulation
Number of subjects: 67
Study 35588750 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS plus embolisation
Number of subjects: 134
Study 35588750 — intervention group
Group type: COMPARATOR
Intervention: TIPS
Number of subjects: 134
Study 33896733 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training (postsimulation group)
Number of subjects: 28
Study 33896733 — intervention group
Group type: COMPARATOR
Intervention: No simulation training (presimulation group)
Number of subjects: 28
Study 33896733 — intervention group
Group type: COMPARATOR
Intervention: Additional mid-rotation simulation training
Number of subjects: 28
Study 32119093 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone coaching app plus home blood pressure monitor
Number of subjects: 333
Study 32119093 — intervention group
Group type: COMPARATOR
Intervention: Blood pressure tracking app plus home blood pressure monitor
Number of subjects: 333
Study 36297080 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Citrulline (10 g)
Number of subjects: 25
Study 36297080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33993905 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 1049
Study 33993905 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 1049
Study 33993905 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 1049
Study 33993905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049
Study 33993905 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (Secukinumab 75 mg, 150 mg, 300 mg)
Number of subjects: 1049
Study 32938481 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced‐Assisted Feedback arm
Number of subjects: 106
Study 32938481 — intervention group
Group type: COMPARATOR
Intervention: Basic arm
Number of subjects: 106
Study 35581905 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone plus exenatide
Number of subjects: 0
Study 35581905 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy or metformin sequentially followed by glipizide and basal insulin
Number of subjects: 0
Study 34737792 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 270
Study 34737792 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 270
Study 33371197 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warning message using red road traffic stop sign ('Stop')
Number of subjects: 78
Study 33371197 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warning message using shocking pictures ('Shock')
Number of subjects: 78
Study 33371197 — intervention group
Group type: COMPARATOR
Intervention: Sweets without warning messages
Number of subjects: 78
Study 36482600 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture
Number of subjects: 0
Study 36482600 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 0
Study 33420717 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based education program (three sessions)
Number of subjects: 130
Study 34784547 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab add-on therapy
Number of subjects: 0
Study 34784547 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC) alone
Number of subjects: 0
Study 33647580 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT)
Number of subjects: 108
Study 33647580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108
Study 33647580 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL)
Number of subjects: 108
Study 33684919 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GH (100 μg/kg/day)
Number of subjects: 35
Study 33684919 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose GH (33 μg/kg/day)
Number of subjects: 35
Study 33684919 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose GH (11 μg/kg/day)
Number of subjects: 35
Study 35622140 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofocal with enhanced intermediate vision lens
Number of subjects: 60
Study 35622140 — intervention group
Group type: COMPARATOR
Intervention: Standard monofocal lens
Number of subjects: 60
Study 33418483 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (1.7 mA, 20 min; n = 27)
Number of subjects: 49
Study 33418483 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (1.7 mA, 30 s; n = 22)
Number of subjects: 49
Study 35932476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density (0.09 mJ/mm2)
Number of subjects: 51
Study 35932476 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium energy density (0.18 mJ/mm2)
Number of subjects: 51
Study 35932476 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy density (0.38 mJ/mm2)
Number of subjects: 51
Study 33256192 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride gel
Number of subjects: 7
Study 33256192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG radiation combined with fluoride gel
Number of subjects: 7
Study 33256192 — intervention group
Group type: COMPARATOR
Intervention: Verbal rating scale (VRS)
Number of subjects: 7